1. Home
  2. NAT vs IOVA Comparison

NAT vs IOVA Comparison

Compare NAT & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nordic American Tankers Limited

NAT

Nordic American Tankers Limited

HOLD

Current Price

$4.18

Market Cap

825.8M

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.57

Market Cap

881.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAT
IOVA
Founded
1995
2007
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
825.8M
881.3M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
NAT
IOVA
Price
$4.18
$2.57
Analyst Decision
Hold
Buy
Analyst Count
2
12
Target Price
$3.25
$10.45
AVG Volume (30 Days)
3.1M
12.9M
Earning Date
02-27-2026
02-26-2026
Dividend Yield
8.06%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$294,820,000.00
$250,425,000.00
Revenue This Year
N/A
$60.71
Revenue Next Year
$24.97
$59.52
P/E Ratio
$468.83
N/A
Revenue Growth
N/A
175.62
52 Week Low
$2.13
$1.64
52 Week High
$4.25
$6.36

Technical Indicators

Market Signals
Indicator
NAT
IOVA
Relative Strength Index (RSI) 70.29 49.67
Support Level $4.12 $2.21
Resistance Level $4.23 $3.03
Average True Range (ATR) 0.12 0.20
MACD 0.01 0.01
Stochastic Oscillator 80.26 43.29

Price Performance

Historical Comparison
NAT
IOVA

About NAT Nordic American Tankers Limited

Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: